{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:43:07Z","timestamp":1773304987079,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T00:00:00Z","timestamp":1374364800000},"content-version":"vor","delay-in-days":1511,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.curtheres.2009.05.004","type":"journal-article","created":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T08:54:23Z","timestamp":1247820863000},"page":"185-196","source":"Crossref","is-referenced-by-count":35,"title":["The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"70","author":[{"given":"Nicola","family":"Giordano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Papakostas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Montella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranuccio","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2009.05.004_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ard.60.2.91","article-title":"Knee pain and osteoarthritis in older adults: Review of community burden and current use of primary health care","volume":"60","author":"Peat","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.curtheres.2009.05.004_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.curtheres.2009.05.004_bib3","first-page":"804","article-title":"A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs","volume":"29","author":"Ofman","year":"2002","journal-title":"J Rheumatol."},{"key":"10.1016\/j.curtheres.2009.05.004_bib4","first-page":"1941","article-title":"Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee","volume":"22","author":"Huskisson","year":"1995","journal-title":"J Rheumatol."},{"key":"10.1016\/j.curtheres.2009.05.004_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [published correction appears in N Engl J Med. 2006;355:221]","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.curtheres.2009.05.004_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Metaanalysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.curtheres.2009.05.004_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.2003.018531","article-title":"Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials","volume":"63","author":"Zhang","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.curtheres.2009.05.004_bib8","first-page":"533","article-title":"Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: Face validity of self-report questionnaire ratings [published correction appears in J Rheumatol. 2005;32:966]","volume":"32","author":"Pincus","year":"2005","journal-title":"J Rheumatol."},{"key":"10.1016\/j.curtheres.2009.05.004_bib9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-122-11-199506010-00011","article-title":"Toward pharmacologic modification of joint damage in osteoarthritis","volume":"122","author":"Brandt","year":"1995","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.curtheres.2009.05.004_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1297-319X(03)00129-5","article-title":"Structure-modifying agents for osteoarthritis: An update","volume":"71","author":"Richette","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.curtheres.2009.05.004_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/rheumatology\/kei171","article-title":"Chondroprotective drugs in degenerative joint diseases","volume":"45","author":"Verbruggen","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.curtheres.2009.05.004_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1063-4584(05)80101-3","article-title":"Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society: Results from a workshop","volume":"4","author":"Altman","year":"1996","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/ard.55.8.552","article-title":"Recommendations for the registration of drugs used in the treatment of osteoarthritis","volume":"55","year":"1996","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.curtheres.2009.05.004_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/1529-0131(200105)44:5<1089::AID-ANR189>3.0.CO;2-9","article-title":"Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants","volume":"44","author":"Noyszewski","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.curtheres.2009.05.004_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/joca.1998.0146","article-title":"Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro","volume":"6","author":"Bassleer","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.joca.2006.06.008","article-title":"Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression","volume":"15","author":"Varghese","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1063-4584(03)00052-9","article-title":"Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes","volume":"11","author":"Dodge","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl","key":"10.1016\/j.curtheres.2009.05.004_bib18","first-page":"147","article-title":"Glucosamine sulfate significantly reduced cartilage destruction in a rabbit model of osteoarthritis","volume":"41","author":"Conrozier","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.curtheres.2009.05.004_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1063-4584(03)00028-1","article-title":"Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes","volume":"11","author":"Largo","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.joca.2005.01.003","article-title":"Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants","volume":"13","author":"Chan","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib21","series-title":"A multicenter, randomized, double-blind, parallel-group study to investigate efficacy and safety of oral glucosamine sulfate in osteoarthritis of the spine","author":"Rovati","year":"1993"},{"key":"10.1016\/j.curtheres.2009.05.004_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1063-4584(05)80006-8","article-title":"Glucosamine sulfate in osteoarthritis of the knee","volume":"2","author":"Noack","year":"1994","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","article-title":"Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis","volume":"283","author":"McAlindon","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.curtheres.2009.05.004_bib24","first-page":"CD002946","article-title":"Glucosamine therapy for treating osteoarthritis","volume":"2","author":"Towheed","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.curtheres.2009.05.004_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.22371","article-title":"Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator","volume":"56","author":"Herrero-Beaumont","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.curtheres.2009.05.004_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2009.05.004_bib27","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study","volume":"162","author":"Pavelk\u00e1","year":"2002","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.curtheres.2009.05.004_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.curtheres.2009.05.004_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/0003-4819-148-4-200802190-00005","article-title":"Effect of glucosamine sulfate on hip osteoarthri-tis: A randomized trial","volume":"148","author":"Rozendaal","year":"2008","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.curtheres.2009.05.004_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.curtheres.2009.05.004_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.curtheres.2009.05.004_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/joca.2000.0361","article-title":"Response criteria for clinical trials on osteoar-thritis of the knee and hip: A report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative","volume":"8","author":"Dougados","year":"2000","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/rheumatology\/30.2.150","article-title":"Prior score availability: Observations using the WOMAC osteoarthritis index","volume":"30","author":"Bellamy","year":"1991","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.curtheres.2009.05.004_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1063-4584(03)00089-X","article-title":"Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee","volume":"11","author":"Salaffi","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib35","first-page":"72","article-title":"The clinical profile of glucosamine sulfate as a selective symptom modifying drug in osteoarthritis: Current data and perspectives","volume":"5","author":"Rovati","year":"1997","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.joca.2005.07.009","article-title":"Glucosamine oral bioavailability and plasma pharmaco-kinetics after increasing doses of crystalline glucosamine sulfate in man","volume":"13","author":"Persiani","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib37","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.joca.2007.01.019","article-title":"Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose","volume":"15","author":"Persiani","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2009.05.004_bib38","first-page":"4062","article-title":"The pharmacokinetics of oral glucosamine and chondroitin sulphate in human","volume":"52","author":"Jackson","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.curtheres.2009.05.004_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/meta.2001.24201","article-title":"Sulfate could mediate the therapeutic effect of glucosamine sulfate","volume":"50","author":"Hoffer","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.curtheres.2009.05.004_bib40","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1172\/JCI118349","article-title":"Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implication for glucose toxicity","volume":"96","author":"Baron","year":"1995","journal-title":"J Clin Invest."},{"key":"10.1016\/j.curtheres.2009.05.004_bib41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0","article-title":"Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoar-thritis of the knee and hip","volume":"43","author":"Cannon","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.curtheres.2009.05.004_bib42","first-page":"1093","article-title":"Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthri-tis of the knee: A combined analysis of the VACT studies","volume":"32","author":"Schnitzer","year":"2005","journal-title":"J Rheumatol."}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X09000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X09000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T09:52:01Z","timestamp":1545126721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X09000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0011393X09000551"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2009.05.004","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}